• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Human papillomavirus and cervical dysplasia in Nunavut: prelude to a screening strategy.

作者信息

Healey Sylvia M, Aronson KristanJ, Mao Yang, Franco Eduardo L

机构信息

Health Protection Unit, Department of Health, Government of Nunavut, Iqaluit, Nunavut, Canada.

出版信息

Int J Circumpolar Health. 2004;63 Suppl 2:199-201. doi: 10.3402/ijch.v63i0.17901.

DOI:10.3402/ijch.v63i0.17901
PMID:15736652
Abstract

OBJECTIVES

To determine the prevalence of oncogenic human papillomavirus' (HPV) in Nunavut and to assess the association between HPV and squamous intraepithelial lesions (SIL) as a prelude to planning a better screening strategy.

STUDY DESIGN

A cross-sectional study was conducted on the Pap-screened populations in 19 communities in Nunavut, Canada. SIL was determined using Liquid-based cytology, and HPV testing was done using the Hybrid Capture II assay.

RESULTS

Prevalence of oncogenic HPVs in 1,290 women ages 13-79 was 26% and of Cervical Dysplasia was 7.2%. Over 90% of women with SIL had positive HPV tests. Over 75% of women who were HPV positive but SIL negative were under 30 years of age.

CONCLUSION

Consideration should be given to using liquid-based cytology for Pap testing. Also consider concurrent HPV testing in those over 30 years old and reflex testing of HPV in those under 30 years old with a positive HPV test.

摘要

相似文献

1
Human papillomavirus and cervical dysplasia in Nunavut: prelude to a screening strategy.
Int J Circumpolar Health. 2004;63 Suppl 2:199-201. doi: 10.3402/ijch.v63i0.17901.
2
Oncogenic human papillomavirus infection and cervical lesions in aboriginal women of Nunavut, Canada.加拿大努纳武特地区原住民妇女的致癌性人乳头瘤病毒感染与宫颈病变
Sex Transm Dis. 2001 Dec;28(12):694-700. doi: 10.1097/00007435-200112000-00006.
3
The degree of agreement between HPV testing, pap smear and colposcopy in cervical dysplasia diagnosis.人乳头瘤病毒(HPV)检测、巴氏涂片检查和阴道镜检查在宫颈发育异常诊断中的一致性程度。
Rev Med Chir Soc Med Nat Iasi. 2012 Apr-Jun;116(2):536-9.
4
Human papilloma virus infection and cervical dysplasia.人乳头瘤病毒感染与宫颈发育异常。
Rev Med Chir Soc Med Nat Iasi. 2012 Jul-Sep;116(3):853-7.
5
Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.法国女性中 HPV 型别感染的流行率:对筛查、疫苗接种和新一代多价 HPV 疫苗的影响。
Vaccine. 2012 Jul 27;30(35):5215-21. doi: 10.1016/j.vaccine.2012.06.013. Epub 2012 Jun 17.
6
Type-specific prevalence of Human Papillomavirus infection among women in the Northwest Territories, Canada.加拿大西北地区女性中 HPV 感染的型别特异性流行率。
J Infect Public Health. 2011 Nov;4(5-6):219-27. doi: 10.1016/j.jiph.2011.09.006. Epub 2011 Nov 3.
7
Human papillomavirus DNA detection in ThinPrep Pap test vials is independent of cytologic sampling of the transformation zone.在液基薄层细胞学检测(ThinPrep Pap test)小瓶中进行人乳头瘤病毒DNA检测,与转化区的细胞学采样无关。
Gynecol Oncol. 2007 Nov;107(2):231-5. doi: 10.1016/j.ygyno.2007.06.025. Epub 2007 Sep 14.
8
The utility of human papillomavirus testing in the management of atypical glandular cells on cytology.人乳头瘤病毒检测在细胞学非典型腺细胞管理中的应用。
J Low Genit Tract Dis. 2009 Apr;13(2):72-8. doi: 10.1097/LGT.0b013e318183bb0e.
9
Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST).人乳头瘤病毒检测与巴氏细胞学检查用于宫颈癌前病变初筛的随机对照试验:加拿大宫颈癌筛查试验(CCCaST)的设计、方法及初步入组结果
Int J Cancer. 2006 Aug 1;119(3):615-23. doi: 10.1002/ijc.21897.
10
Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing.收集于液体缓冲液中的宫颈标本适用于细胞学筛查和辅助人乳头瘤病毒检测。
Cancer. 1997 Apr 25;81(2):89-97.

引用本文的文献

1
Type-specific human papillomavirus infections and Pap test findings in Inuit and non-Inuit women in Nunavut, Canada.加拿大努纳武特地区因纽特和非因纽特女性的特定型人乳头瘤病毒感染及巴氏试验结果
Can Commun Dis Rep. 2015 Mar 5;41(3):43-51. doi: 10.14745/ccdr.v41i03a01.
2
Canadian oncogenic human papillomavirus cervical infection prevalence: systematic review and meta-analysis.加拿大致癌型人乳头瘤病毒宫颈感染的流行率:系统评价和荟萃分析。
BMC Infect Dis. 2011 Sep 5;11:235. doi: 10.1186/1471-2334-11-235.